Literature DB >> 18729310

Multiple endocrine neoplasia type 1 with multiple leiomyomas linked to a novel mutation in the MEN1 gene.

Heekyoung Choi1, Sehyun Kim, Jae-Hoon Moon, Yoon Hee Lee, Yumie Rhee, Eun Seok Kang, Chul Woo Ahn, Bong Soo Cha, Eun Jig Lee, Kyung Rae Kim, Hyun Chul Lee, Seon Yong Jeong, Hyun Ju Kim, Sung-Kil Lim.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominantly inherited syndrome. MEN1 is characterized by the presence of functioning and nonfunctioning tumors or hyperplasia of the pituitary gland, parathyroid glands, and pancreatic islet cells. In addition, MEN1 carriers can have adrenal or thyroid tumors and non-endocrine tumors, such as lipomas, angiofibromas, and leiomyomas. Although leiomyoma is not a major component of MEN1, it is thought to occur more frequently than expected. However, there has been no report of a case of MEN1 with leiomyoma in Korea so far. This report describes a patient with multiple leiomyomas in MEN1. A 50-year-old woman was referred for further evaluation of elevated calcium levels and osteoporosis. Biochemical abnormalities included hypercalcemia with elevated parathyroid hormone. There was hyperprolactinemia with pituitary microadenoma in sella MRI. An abdominal MRI demonstrated adrenal nodules and leiomyomas in the bladder and uterus. Endoscopic ultrasonography demonstrated esophageal leiomyoma and pancreatic islet cell tumor. A subtotal parathyroidectomy with thymectomy was performed. Sequencing of the MEN1 gene in this patient revealed a novel missense mutation (D350V, exon 7). This is the first case of MEN1 accompanied with multiple leiomyomas, parathyroid adenoma, pituitary adenoma, pancreatic tumor, and adrenal tumor.

Entities:  

Mesh:

Year:  2008        PMID: 18729310      PMCID: PMC2615294          DOI: 10.3349/ymj.2008.49.4.655

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  17 in total

1.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

2.  Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.

Authors:  Q Dong; L V Debelenko; S C Chandrasekharappa; M R Emmert-Buck; Z Zhuang; S C Guru; P Manickam; M Skarulis; I A Lubensky; L A Liotta; F S Collins; S J Marx; A M Spiegel
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

3.  Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

Authors:  S K Agarwal; M B Kester; L V Debelenko; C Heppner; M R Emmert-Buck; M C Skarulis; J L Doppman; Y S Kim; I A Lubensky; Z Zhuang; J S Green; S C Guru; P Manickam; S E Olufemi; L A Liotta; S C Chandrasekharappa; F S Collins; A M Spiegel; A L Burns; S J Marx
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

Review 4.  Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

Authors:  S S Guo; M P Sawicki
Journal:  Mol Endocrinol       Date:  2001-10

5.  Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.

Authors:  S Pack; M L Turner; Z Zhuang; A O Vortmeyer; R Böni; M Skarulis; S J Marx; T N Darling
Journal:  J Invest Dermatol       Date:  1998-04       Impact factor: 8.551

6.  Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.

Authors:  J F Roijers; M J de Wit; R B van der Luijt; H K Ploos van Amstel; J W Höppener; C J Lips
Journal:  Eur J Clin Invest       Date:  2000-06       Impact factor: 4.686

7.  Genotype-phenotype analysis in multiple endocrine neoplasia type 1.

Authors:  Maria A Kouvaraki; Jeffrey E Lee; Suzanne E Shapiro; Robert F Gagel; Steven I Sherman; Rena V Sellin; Gilbert J Cote; Douglas B Evans
Journal:  Arch Surg       Date:  2002-06

8.  Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

Authors:  Virginie Wautot; Cécile Vercherat; James Lespinasse; Béatrice Chambe; Gilbert M Lenoir; Chang X Zhang; Nicole Porchet; Martine Cordier; Christophe Béroud; Alain Calender
Journal:  Hum Mutat       Date:  2002-07       Impact factor: 4.878

9.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

Authors:  C Larsson; B Skogseid; K Oberg; Y Nakamura; M Nordenskjöld
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

10.  Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.

Authors:  J L McKeeby; X Li; Z Zhuang; A O Vortmeyer; S Huang; M Pirner; M C Skarulis; L James-Newton; S J Marx; I A Lubensky
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

View more
  3 in total

1.  Multiple Uterine Leiomyomas in Multiple Endocrine Neoplasia Type 1 with a Novel MEN1 Gene Mutation.

Authors:  Raiz Ahmad Misgar; Danendra Sahu; Sameer Purra; Arshad Iqbal Wani; Mir Iftikhar Bashir
Journal:  J Hum Reprod Sci       Date:  2020-04-07

2.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

3.  Genetic and epigenetic analysis in korean patients with multiple endocrine neoplasia type 1.

Authors:  Yoon Jung Chung; Sena Hwang; Jong Ju Jeong; Sun Yong Song; Se Hoon Kim; Yumie Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.